Literature DB >> 23277039

The role of innate signals in B cell immunity to influenza virus.

Stephen O Priest1, Nicole Baumgarth.   

Abstract

Decades of research on mammalian immunity to influenza virus infection have thoroughly established the important contributions made by both the innate and adaptive responses in containing the infection, and in eliminating the virus and protecting from reinfection, respectively. While rapid non-specific innate response is functionally distinct from, yet elegantly complementary to, the delayed-but-specific adaptive response, an increasing number of studies have provided evidence suggesting signals generated during the early innate response can have a significant impact on the quality of the later adaptive response, particularly in the context of influenza virus infection. From these findings emerged the notion that certain innate signals can act directly on B cells, and that this can even help activate virus specific B cells independent of T cell help, marking a major shift away from the current two-signal paradigm of lymphocyte activation. Here we review the current understanding of early B cell responses to influenza virus infection and the role of innate signals (particularly IFN-I and TLR7) in shaping this response.

Entities:  

Mesh:

Year:  2013        PMID: 23277039     DOI: 10.2741/s360

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  4 in total

1.  Cellular scent of influenza virus infection.

Authors:  Alexander A Aksenov; Christian E Sandrock; Weixiang Zhao; Shankar Sankaran; Michael Schivo; Richart Harper; Carol J Cardona; Zheng Xing; Cristina E Davis
Journal:  Chembiochem       Date:  2014-04-09       Impact factor: 3.164

2.  Both B-1a and B-1b cells exposed to Mycobacterium tuberculosis lipids differentiate into IgM antibody-secreting cells.

Authors:  Ciara Ordoñez; Hannah P Savage; Musharaf Tarajia; René Rivera; Cheyenne Weeks-Galindo; Dilcia Sambrano; Lee Riley; Patricia L Fernandez; Nicole Baumgarth; Amador Goodridge
Journal:  Immunology       Date:  2018-02-18       Impact factor: 7.397

Review 3.  AS03- and MF59-Adjuvanted Influenza Vaccines in Children.

Authors:  Amanda L Wilkins; Dmitri Kazmin; Giorgio Napolitani; Elizabeth A Clutterbuck; Bali Pulendran; Claire-Anne Siegrist; Andrew J Pollard
Journal:  Front Immunol       Date:  2017-12-13       Impact factor: 7.561

Review 4.  Immune responses in influenza A virus and human coronavirus infections: an ongoing battle between the virus and host.

Authors:  Jian Zheng; Stanley Perlman
Journal:  Curr Opin Virol       Date:  2017-11-21       Impact factor: 7.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.